Aktie A002390 HANDOK INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen HANDOK Inc.

Aktien

A002390

KR7002390003

A002390

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 02.07.2024 		% 5 Tage % 1. Jan.
16 460 KRW +2,68 % Intraday Chart für HANDOK Inc. +12,82 % +15,10 %
24.05. Biocon schließt sich mit Handok zusammen, um das Antidiabetikum Liraglutid in Südkorea zu vermarkten MT
24.05. Biocon Limited unterzeichnet exklusiven Lizenz- und Liefervertrag für die Vermarktung von Liraglutid in Südkorea mit Handok Inc. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
WELT Corp., Ltd announced that it has received KRW 14 billion in funding from Envisioning Partners, Korea Development Bank, Investment Arm, Shinhan Venture Investment Co, Ltd., IMM Investment, Corp., HANDOK Inc.
Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea
Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc
Nxera Pharma Partners with Handok c. to Distribute PIVLAZ in South Korea,
Nxera Pharma Announces Exclusive Supply and Distribution Agreement with Handok for Pivlaz in South Korea
Sobi and Handok establish joint venture for rare disease business in South Korea
Sobi to Expand in South Korea via Rare Disease JV with Handok
HANDOK Inc.(KOSE:A002390) dropped from S&P Global BMI Index
Hogere omzet en kleiner verlies voor Argenx
HANDOK Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Rezolute Unveils Plans for Secondary Offering of 3.24 Million Shares
I-Mab Completes Enrollment in China Phase 3 Trial of Eftansomatropin Alfa in Pediatric Growth Hormone Deficiency
AUM Biosciences Enters in A Strategic Collaboration with Handok and CMG Pharm to Develop ‘CHC2014’, New Pan-TRK Inhibitor for Cancer Treatment
WELT Corp., Ltd announced that it has received KRW 6 billion in funding from HANDOK Inc., Smilegate Investment, Inc., POSCO Venture Capital Co., Ltd.
Adicet Bio, Inc. announced that it has received $80 million in funding from a group of investors
Rezolute, Inc. announced that it has received $24.05 million in funding from Genexine, Inc., Handok, Inc., District 2 Capital Fund LP, The Bigger Capital Fund, LP and another investor
Adicet Bio, Inc. announced that it expects to receive $80 million in funding
Rezolute, Inc. announced that it expects to receive $20.25 million in funding from District 2 Capital Fund LP, The Bigger Capital Fund, LP, Genexine, Inc., Handok, Inc.
TRIGR Therapeutics, Inc announced that it has received $14 million in funding from Handok Inc.
BiomX Ltd announced that it has received $32 million in funding from a group of investors
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A002390 Aktie
  4. Nachrichten HANDOK Inc.
  5. Andere Sprachen